Publicaciones en colaboración con investigadores/as de University College London (4)

2022

  1. Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis

    Journal of Medicinal Chemistry, Vol. 65, Núm. 3, pp. 1867-1882

2018

  1. The APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca 2+ dysregulation, and mitochondrial abnormalities

    Journal of Neurochemistry, Vol. 145, Núm. 2, pp. 170-182

2017

  1. Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease

    Scientific Reports, Vol. 7

2009

  1. A global benchmark study using affinity-based biosensors

    Analytical Biochemistry, Vol. 386, Núm. 2, pp. 194-216